1. Home
  2. IMMP vs BKSY Comparison

IMMP vs BKSY Comparison

Compare IMMP & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immutep Limited

IMMP

Immutep Limited

N/A

Current Price

$4.86

Market Cap

42.4M

Sector

Health Care

ML Signal

N/A

Logo BlackSky Technology Inc.

BKSY

BlackSky Technology Inc.

HOLD

Current Price

$22.98

Market Cap

839.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMP
BKSY
Founded
1987
2013
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
42.4M
839.0M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
IMMP
BKSY
Price
$4.86
$22.98
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$5.50
★ $28.50
AVG Volume (30 Days)
357.6K
★ 827.0K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 21.72
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$445.09
$27.03
Revenue Next Year
N/A
$29.21
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$12.41
52 Week High
$3.53
$52.88

Technical Indicators

Market Signals
Indicator
IMMP
BKSY
Relative Strength Index (RSI) 97.69 50.11
Support Level $2.65 $20.05
Resistance Level N/A $24.35
Average True Range (ATR) 0.07 1.24
MACD 0.28 0.37
Stochastic Oscillator 89.42 86.56

Price Performance

Historical Comparison
IMMP
BKSY

About IMMP Immutep Limited

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a space-based technology company that delivers real-time imagery, analytics and high-frequency monitoring of the worlds critical and strategic locations, economic assets, and events. By taking a software-first technology approach, Company is delivering real-time space-based intelligence at disruptive speed, scale and economics. Companies single operating and reportable segment, provided space-based intelligence products and services through three integrated revenue streams-space-based intelligence & AI services, mission solutions, and technology programs. Geographically, the company operates in United States and Rest of world.

Share on Social Networks: